IMMX
Immix Biopharma Inc
9.70$
-5.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +0.0% | +0.0% | -38.2% | +47.8% | +0.0% | -10.8% | +0.2% | +172.9% | +122.7% | +675.4% | +1.9% | +6.6% | – | – | +34.9% | – | – | +44.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,496.4% | – | – | – | -222.9% | – | – | – | – | – | – | |
| – | 0.0% | -25.0% | +85.4% | -70.2% | +152.7% | -52.7% | -68.9% | +6,716.1% | -3.5% | +14.5% | +225.1% | -41.7% | +67.5% | -4.7% | +47.2% | +4.8% | -31.5% | +99.9% | -69.1% | +43.7% | +101.1% | +15.4% | +24.9% | +4.4% | -10.8% | – | |
| – | 0.0% | +3.8% | +51.8% | +96.0% | +31.0% | +76.4% | +85.1% | +18.9% | +36.1% | -12.1% | +82.9% | -21.6% | +25.8% | +60.0% | -5.9% | +2.9% | +5.8% | +19.0% | +22.5% | -25.0% | +1.4% | +12.1% | +67.8% | -6.6% | +47.7% | – | |
| – | +0.0% | -12.7% | +68.3% | +5.8% | +49.6% | +43.1% | +71.9% | +122.3% | +17.4% | -1.8% | +147.5% | -33.6% | +47.6% | +21.6% | +18.8% | +4.0% | -15.9% | +57.3% | -32.6% | -6.1% | +43.5% | +14.1% | +42.2% | -0.8% | +15.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +5.6% | +11.6% | +95.6% | +0.1% | -17.5% | -99.1% | -71.9% | +49,383.5% | -99.1% | +9,207.8% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.1% | -2.5% | +614.3% | -87.1% | +1.1% | -16.9% | +10.5% | +9.8% | +5.7% | -2.5% | +214.5% | -1.7% | +22.8% | +7.2% | +18.8% | +9.3% | +16.2% | +8.5% | -3.2% | -8.9% | -9.2% | -13.4% | +45.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.